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a b s t r a c t
n-3 Polyunsaturated fatty acids (n-3PUFAs) may be beneﬁcial for anxiety and depression under stressful
conditions. Studies however, typically utilise physical or sudden physiological stress, while gradual
physiological stress is also relevant to human conditions. Using deoxycorticosterone acetate (DOCA)
administration to induce gradual physiological stress, this study investigated the impact of n-3PUFAs
under gradual physiological stress in rats. Animals (aged 2 months) (N¼8–12/group) received daily
injections of DOCA or vehicle and were concurrently fed a high n-3PUFA or control diet for eight weeks.
Behavioural measures were taken throughout. Behavioural tests and physiological measures were
conducted after six and eight weeks respectively. DOCA administration decreased plasma renin, plasma
proteins and relative adrenal weight, and increased water intake, relative kidney weight, and anxiety in
the open ﬁeld. These ﬁndings demonstrate disruptions to the renin–angiotensin–aldosterone system, a
result of mild physiological stress, that also impact on anxiety behaviours. No effects of n-3PUFAs
were found.
& 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
1. Introduction
N3 long chain polyunsaturated fatty acids (n-3PUFAs) have been
suggested as a possible treatment for depressive and anxiety condi-
tions [1–3]. Various studies demonstrate beneﬁcial effects in both
humans and animals, although evidence is mixed [1–3]. In rats
speciﬁcally, several studies currently suggest an effect of n-3PUFAs
on anxiety- and depressive-related behaviours e.g. [4,5], although not
all studies demonstrate effects or consistent effects e.g. [6,7].
The discrepancies between studies have been suggested to
result from differences in stress [3,8–10]. Acute physical stress, as a
result of a brightly lit or noisy test situation, and chronic physical
stress, e.g. through several weeks of restraint stress, have resulted
in the demonstration of greater beneﬁts of n-3PUFAs than less
stressful situations or experiences e.g. [3,8,11]. Physiological stress,
as a result of injury and/or inﬂammation has also resulted in
enhanced impacts of n-3PUFAs [12–16]. Again, however, effects of
n-3PUFAs are inconsistent, and conclusions difﬁcult to draw.
Troﬁmuik and Braszko [17], for example, demonstrate no effects
of n-3PUFA supplementation in open ﬁeld and elevated plus maze
tests following 2 h/day restraint stress for 21 days, Song et al. [18]
demonstrate inconsistent effects of n-3PUFAs in the open ﬁeld test
following injections to induce inﬂammation, and Plamandon and
Roberge [19] demonstrate no effects of n-3PUFA supplementation
in open ﬁeld and elevated plus maze tests following forebrain
ischaemic surgery. n-3PUFA supplementation even enhanced the
deleterious effects of chronic mild stress for 6 weeks in the novelty
suppression of feeding test (animals fed after a longer latency) as
conducted by Vancassel et al. [10]. Chalon et al. [20] also report
decreased activity in the open ﬁeld test following n-3PUFA
supplementation in combination with restraint stress, and Carrie
et al. [5] and Nakashima et al. [21] report reversed effects on
anxiety behaviours (reduced exploration of the open arms of the
elevated plus maze).
Studies in animals are intended to model human conditions,
but human depressive and anxiety conditions are known to result
not just from sudden or high levels of stress, but also from more
mild but long term stressors such as changes in lifestyle or gradual
failures in health e.g. [22,23]. Effects of mild long term physical
stressors have been investigated using the chronic mild stress
model (with mixed results for n-3PUFAs), e.g. [10], but as far as we
are aware, effects in response to gradual physiological changes or
gradual physiological stress, have not been investigated. Gradual
physiological stress compared to sudden physiological onslaughts
may more closely reﬂect a human situation where regulatory
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systems are gradually disrupted by changes to lifestyle [24–27],
and thus warrants investigation.
Given the previous evidence that n-3PUFAs may be dependent
on the level of stress to inﬂuence depression- and anxiety-relevant
behaviours, this study aimed to investigate the impact of n-3PUFAs
on anxiety- and depressive behaviours in rats under gradual
physiological stress. The renin–angiotensin–aldosterone system is
a stress-responsive system in the body, known to be inﬂuenced by
mild stressors in humans and animals [28–31]. Alterations to this
system may serve as a form of mild physiological stress, allowing
investigation of the interactions between mild gradual physiolo-
gical stress and behavioural and physiological responses to n-
3PUFAs. Deoxycorticosterone acetate (DOCA) is a mineralocorti-
coid agonist, known to disrupt the renin–angiotensin–aldosterone
system. Previous studies demonstrate increased salt appetite and
increased anxiety- and depressive-behaviours in rats following
DOCA administration in the absence of excess salt for consumption
[32]. In the present study, we tested the hypothesis that DOCA
administration would produce both depressive- and anxiety-
relevant behaviours in rats, and that a diet high in
n-3PUFAs would prevent these behavioural alterations.
2. Methods
2.1. Animals
Forty-two male Sprague Dawley rats (Harlan Sprague, Indiana-
polis, IL), aged two months and weighing 200–250 g at the start of
the study were used. Animals were housed individually in a
standard animal facility on a 12 h light/dark cycle (lights on at
6 a.m.), temperature 20–22 1C, with ad-libitum access to food and
water. Animals were allowed to adapt to the animal facility for 12
days before study procedures commenced. All study procedures
were implemented only after adaptation to the animal facility
(i.e. no procedures were undertaken during weaning, or prior to
birth). Use of weaned animals was intended to more closely
resemble a human situation where n-3PUFA provision can be
adequate during pregnancy and weaning, as a result of maternal
resources. All procedures were conducted in accordance with the
National Institutes of Health Guide for the Care and Use of
Laboratory Animals and were approved by The University of Iowa
Animal Care and Use Committee.
2.2. General study design
Following adaptation to the animal facility, all rats were subjected
to gradual physiological stress vs. no stress, and concurrently received
a high n-3PUFA diet vs. a control diet (minimal n-3PUFAs), and effects
on behaviour and physiology were measured. Gradual physiological
stress was induced using administration of DOCA in the absence of
excess salt for consumption. Animals were treated with DOCA and
given ad-libitum access to allocated high n-3PUFA or control diets for
a period of eight weeks. Effects of n-3PUFA supplementation for this
duration have previously been demonstrated e.g. [4,33]. The combina-
tion of DOCA treatment and n-3PUFA provision resulted in the
maintenance of four groups of animals throughout the study: (a) VC
– vehicle treatment/control diet (N¼8); (b) Vn3 – vehicle treatment/
n-3PUFA diet (N¼8); (c) DC – DOCA treatment/control diet (N¼12);
and (d) Dn3 – DOCA treatment/n-3PUFA diet (N¼12).
2.3. DOCA administration
Animals were either treated with: DOCA (10 mg/kg suspended
in 1 ml/kg safﬂower oil); or vehicle only (1 ml/kg safﬂower oil).
Subcutaneous injections were given daily from 10.00–12.00 a.m.
All animals were also handled daily following injections. Salt
provision was maintained at standard levels (based on usual
physiological requirements) for all animals [34] (Table 1).
2.4. n-3PUFA supplementation
Concurrently with DOCA administration, half of the animals in
each group were fed either: an n-3PUFA supplemented diet
(Research Diets, Inc., New Brunswick, US); or an n-3PUFA deﬁcient
diet (control) (Research Diets, Inc., New Brunswick, US). Diets were
based on the AIN-93G growing rodents diet [34], and were
identical in all aspects except fat source and n-3PUFA provision
(Table 1). The levels of n-3PUFA provided have previously been
found to impact on behavioural tests as used here e.g. [4]. Diets
were stored in airtight containers and provided fresh every other
day to prevent decomposition due to exposure to the atmosphere.
N-3PUFA supplementation as opposed to deprivation was used to
more closely resemble a human situation, and concurrent n-3PUFA
provision was used to mimic a prevention as opposed to a
treatment scenario.
Table 1
Composition of control and n-3PUFA diets.
Nutrients Control n-3PUFA
Protein (g/100 g food) 19.8 19.8
CHO (g/100 g food) 66.8 66.8
Fat (g/100 g food) 4.9 4.9
Fat source Safﬂower oil (mg/100 g food) 25 25
High oleic safﬂower oil (mg/100 g food) 25
Menhaden oil (mg/100 g food) 25
Fatty acid provision Saturated (%fat) 8.1 18.4
Monounsaturated (%fat) 45.3 17.7
Polyunsaturated (%fat) 46.5 63.5
Linoleic acid (%fat) 46.5 42.6
Alpha-Linolenic acid (%fat) 0.1 0.9
Eicosapentaenoic acid (%fat) 0 7.5
Docosahexaenoic acid (%fat) 0 5.4
Total n-3PUFAs (%fat) 0.1 17.0
Total n-3PUFAs (g/100 g food) 0.003 0.82
Total n-6PUFAs (g/100 g food) 2.32 2.08
Salt (g/100 g food) 2.59 2.59
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2.5. Outcome measures
Effects of DOCA administration and n-3PUFAs were investi-
gated using regular measures of water intake, food intake, body
weight and sucrose intakes; measures of behaviour at six weeks in
open ﬁeld, elevated plus maze and forced swim tests; and
physiological measures of plasma sodium, haematocrits, proteins,
osmolality, plasma renin and organ weight (heart, lungs, kidneys,
adrenals) in relation to body weight, at eight weeks.
2.5.1. Water intake, food intake, body weight
Food and water intakes were measured on random days (2–4
days/week) throughout the study by weighing food and water
containers. Body weights were measured weekly using a standard
animal balance.
2.5.2. Sucrose intake
Sucrose intake tests were used as an operational index of
anhedonia [32,35]. Animals were presented with access to a 2%
sucrose solution (2 g sucrose/100 g water) for one hour, from
8:00–9:00 a.m., and amount consumed in that hour was mea-
sured. Animals were adapted to the hourly exposure in days 3–7 of
their initial adaptation to the animal facility, and baseline readings
were taken on days 10 and 11 of adaptation. Sucrose intake testing
was conducted weekly on two consecutive days as occurred at
baseline. Access to food and water were not restricted during
sucrose intake tests.
2.5.3. Open ﬁeld
The open ﬁeld test was used as an operational index of anxiety-
relevant and exploratory behaviours [3]. Our open ﬁeld consists of
a 1 m1 m black plastic square surrounded by 38 cm high walls,
the base of which is divided by markings into 9 equal squares of
approx. 33 cm2, eight around the edge of the square and one in the
centre. Animals were placed in the centre of the central square at
the start of the test and allowed to move freely for a 5 min period.
Tests were conducted under bright lighting for half of the animals
and dim lighting for half of the animals (evenly distributed
between groups), from 9 a.m. to 2 p.m., and equipment was
cleaned with 70% ethanol solution between animals. Bright light-
ing was used to enhance the stressful nature of the test [3].
Number of lines crossed (between squares), number of central
lines crossed (to enter/leave the central square), time in the central
square at the start, total time in the central square and number of
rears were recorded. Line crosses were deﬁned as a cross by all
four paws, time in the central square was determined by the
position of the two ears.
2.5.4. Elevated plus maze
The elevated plus maze was used as an operational index of
anxiety-relevant and exploratory behaviours [3]. The elevated plus
maze consists of 2 open arms (50 cm10 cm) and 2 closed arms
(50 cm10 cm), separated by a 10 cm10 cm central area. The
closed arms are surrounded by 48 cm high walls. The entire maze
is made of black plastic and elevated 50 cm from the ﬂoor. Animals
were placed in the central area facing an open arm, and allowed to
move freely in the maze for 5 min. Tests were conducted under
dim lighting from 9 a.m. to 2 p.m., three days after the open ﬁeld
test was conducted. Equipment was cleaned with 70% ethanol
solution between animals. Number of entries into open and closed
arms, and amount of time spent in open and closed arms were
recorded. Entry into an arm was deﬁned by presence in the arm of
the two forepaws, and time spent in an arm was deﬁned by
location of the two ears. Bright and dim lighting was not used in
the elevated plus maze to avoid confounding as a result of lighting
condition in the open ﬁeld test.
2.5.5. Forced swim test
The forced swim test was used as an operational index of
behavioural despair [3]. The forced swim test uses a transparent
plastic cylinder (15 cm diameter) ﬁlled to a depth of 30 cm with
tap water of 23–25 1C, from which no escape is possible. Animals
were placed in the water and allowed to move freely for 5 min.
The forced swim test is traditionally conducted using 2 trials – one
of 15 min followed by a further trial of 5 min 24 h later, to result in
a learned helplessness in the animal and subsequent despair [3].
Only one trial was used to demonstrate effects of anhedonia, as
opposed to effects of learning [36]. Only one trial has previously
been demonstrated as sufﬁcient to demonstrate anhedonia [36],
and has been suggested as a more accurate reﬂection of emotion in
the absence of learning [36]. The impact of n-3PUFAs on learning
has been suggested e.g. [14,17]. Tests were conducted three days
after the elevated plus maze was completed, under dim lighting
from 9 a.m. to 3 p.m. Water was changed after every animal. Time
spent actively trying to escape from the start to the ﬁrst period of
immobility, and total time spent actively trying to escape were
recorded. Active escape movements included swimming (active
forward movement on the surface of the water), diving (active
forward movement under the water) and climbing (active move-
ment with the forepaws towards the walls of the cylinder).
Immobility was deﬁned as minimal movement sufﬁcient only to
keep the animal from drowning. Swimming, diving, and climbing
were summed to provide one index of active escape activity; and
immobility was used as the operational index of behavioural
despair, according to previous tests of validity [3].
For the open ﬁeld, elevated plus maze, and the forced swim tests,
animals were tested in a random order within blocks of 10–12 animals
with roughly even numbers from all experimental groups per block,
and even numbers under bright and dim conditions during the open
ﬁeld test. All animals undertook the open ﬁeld test (either in bright or
dim lighting), then the elevated plus maze test, then the forced swim
test. Each animal only took each test once. All tests were conducted as
recommended [3,36]. All measures were coded independently by two
researchers using video recordings taken from directly above. Dis-
crepancies between researchers of more than 5% were recoded until
agreement within 5% was reached.
2.5.6. Plasma measures
At the end of the study, trunk blood was collected following
decapitation and placed into a tube containing an anti-coagulant.
Blood was centrifuged at 4 1C at 3500 rpm for 15 min to obtain
plasma, and stored at 80 1C. Plasma osmolality was determined
using a freezing-point osmometer (Model 5004, Precision Systems,
Natick, MA); plasma sodium concentrations were measured in a
Naþ/Kþ analyser with ion-speciﬁc electrodes (Nova 1. Nova
Biomedical, Walthan, MA). Plasma proteins (total proteins) were
determined by refractometer (National Instrument, Baltimore,
MD). Plasma renin activity was measured using commercially
available kits. All procedures were conducted according to pre-
viously published methodology [28].
2.5.7. Organ weight
Following decapitation, heart, lungs, kidneys and adrenals were
harvested and weighed in relation to body weight.
2.6. Analyses
Data were analysed for differences dependent on DOCA admin-
istration (groups V vs. D), diet (groups C vs. n3) and interactions
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between these, using repeated measures ANOVA or univariate
ANOVA as appropriate. Data from the open ﬁeld test, elevated plus
maze test and forced swim test were analysed by MANOVA (one
per test). Analyses on data from the open ﬁeld test also investi-
gated differences dependent on lighting condition (bright vs. dim)
and all associated interactions as above. Parametric tests were
used following assessment of the data to ensure that assumptions
were not violated.
3. Results
3.1. Water intakes, food intake and body weight
DOCA-treated animals consumed signiﬁcantly more water than
vehicle animals over time (F(11,418)¼3.15, po0.01), but no effects
were found dependent on diet (largest F(11, 363)¼0.68, p¼0.62).
Signiﬁcant increases in body weight (F(7,266)¼808.76, po0.01),
and decreases in food intake (F(11,363)¼41.92, po0.01) were
found over time, but no differences were found dependent on
DOCA administration or diet (largest F(11,363)¼1.36, p¼0.19).
Water intakes, food intakes and body weight are provided in Fig. 1.
3.2. Sucrose intakes
Sucrose intakes also increased over time (F(7,266)¼12.04,
po0.01), but no effects of DOCA treatment or n-3PUFAs were
found (largest F(7,266)¼1.48, p¼0.17). Sucrose intakes are dis-
played in Fig. 2.
3.3. Open ﬁeld, elevated plus maze, forced swim tests
Results from all three tests are displayed in Figs. 3–5. Signiﬁ-
cant effects were found only in the open ﬁeld test. In brightly lit
conditions, rats performed signiﬁcantly less crosses of the central
lines (F(1,34)¼4.30, p¼0.05), line crosses in total (F(1,34)¼10.27,
po0.01), and signiﬁcantly less rears than in dimly lit conditions
(F(1,34)¼11.03, po0.01). DOCA-treated rats also performed sig-
niﬁcantly less line crosses in total compared to vehicle-treated
rats, regardless of lighting (F(1,34)¼4.79, p¼0.04). No effects of
n-3PUFA treatment were found (largest F(1,34)¼2.28, p¼0.14).
There were no signiﬁcant effects in the elevated plus maze test
(largest F(1,41)¼1.17, p¼0.29), or the forced swim test (largest F
(1,41)¼1.67, p¼0.20), but there was a trend towards a difference
between DOCA- and vehicle-treated animals across both measures
of activity in the forced swim test (F(2,60)¼2.37, p¼0.09), where
DOCA-treated animals spent less time in escape activity than
vehicle-treated animals.
3.4. Plasma renin, sodium, haematocrits, proteins, osmolality
and organ weight
Plasma and organ weight measures are given in Table 2. Plasma
renin and plasma proteins were signiﬁcantly lower in DOCA-
treated animals compared to vehicle (F(1,21)¼4.84, p¼0.04;
F(1,19)¼32.34, po0.01 respectively). Plasma sodium, haemato-
crits and osmolality, did not differ between DOCA treated and
untreated animals (largest F(1,23)¼1.54, p¼0.23). Relative
weights of hearts and lungs also did not differ (largest F(1,24)¼
0.19, p¼0.67), but weights of kidneys were signiﬁcantly higher
and weights of adrenals were signiﬁcantly lower in relation to
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body weight in DOCA-treated animals compared to vehicle (smal-
lest F(1,27)¼4.56, p¼0.04). No differences were found dependent
on diet (largest F(1,23)¼2.03, p¼0.17).
4. Discussion
This study investigated the impact of a high n-3PUFA diet on
anxiety- and depressive behaviours in rats, during concurrent
DOCA administration. Results indicate that: (1) chronic DOCA
administration (in the absence of excess salt) increased water
intake, increased the relative weight of kidneys, decreased plasma
renin and plasma proteins, and decreased the relative weight of
the adrenals; (2) chronic DOCA administration increased anxiety-
related behaviours; and (3) n-3PUFAs did not impact on any of the
measures employed.
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Increases in water intake, increases in the relative weight of the
kidneys, and decreases in plasma renin and plasma proteins in
response to DOCA administration in the absence of excess salt are
consistent with previous studies. These effects have been reported
elsewhere as a result of DOCA and aldosterone administration
[26,27], and demonstrate disruptions to the renin–angiotensin–
aldosterone system [29–31]. The present ﬁndings contribute to
these previous results, demonstrating that the administration of
DOCA for 8 weeks is sufﬁcient to disrupt the renin–angiotensin–
aldosterone system. These disruptions mimic those that may be
achieved in humans as a result of mild stressors, such as daily
stressors, lifestyle changes or failures in health [24–27].
In addition to physiological disruptions to the renin–angioten-
sin–aldosterone system, DOCA administration resulted in anxiety-
relevant behaviours in the open ﬁeld test, and in trends towards
depression-related behaviours in the forced swim test. Brightly lit
conditions also resulted in increased anxiety-related behaviours.
Anxiety-related effects as a result of a bright test situation have
previously been demonstrated, and demonstrate the validity of the
tests used here [3]. Effects in relation to DOCA administration
suggest that disruptions to the renin–angiotensin–aldosterone
system via gradual DOCA administration inﬂuence anxiety- and
depression-relevant behaviours in rats. Behavioural alterations are
likely to have resulted from a gradual adaption to the physiological
disruption caused by the DOCA administration [26,27], and in
combination with the physiological disruptions in hormone and
organ weights, suggest that DOCA administration may be a useful
protocol for inducing and investigating mild gradual physiological
stress. The present ﬁndings are consistent with previous data
indicating that mild stressors contribute to depressive and parti-
cularly anxiety disorders in humans [22,23]. We are unclear why
anxiety-relevant behaviours were not observed in the elevated
plus maze test. We can only suggest that following our protocol,
where the open ﬁeld test ﬁeld was conducted ﬁrst and in stressful
conditions for half the animals, the open ﬁeld test was more
anxiety-provoking than the elevated plus maze test.
Contrary to our hypotheses, no effects of n-3PUFAs were found
in the present study. These ﬁndings suggest no effects of n-3PUFAs
on either behavioural or physiological measures under conditions
of mild gradual physiological stress. The current data are consis-
tent with previous studies indicating an absence of effects of
n-3PUFAs under non-stressful conditions. Many studies using
stress and no-stress comparisons report effects of n-3PUFAs under
stressful conditions, but not in situations of no stress. Song et al.
demonstrate reduced anxiety-related effects in the open ﬁeld [14]
and elevated plus maze tests [14,15] following a high n-3PUFA diet
under IL-1β administration, but not following saline administra-
tion. Kozak et al. [12] report reduced behavioural effects of
induced inﬂammation in n-3PUFA treated animals, but no effects
of n-3PUFAs in control animals (no induced inﬂammation), and
Harauma & Moriguchi [8] report beneﬁcial effects of n-3PUFA
supplementation in response to isolation but not in animals
housed in groups. Studies employing only stressful conditions also
tend to report beneﬁcial effects of n-3PUFAs. Ferraz et al. [11], for
example, report reduced effects of restraint stress following
n-3PUFA supplementation. Studies employing only no-stress con-
ditions typically report no effects of n-3PUFAs. Without deliber-
ately increasing stress, Carlezon et al. [4], Coluccia et al. [37] and
Ferraz et al. [7] report no effects of n-3PUFA supplementation on
activity in the open ﬁeld, Belzung et al. [6] found no effects in
ambulatory activity or anxiety-related activity in the elevated plus
maze, and Shalbudina et al. [38] found no effects in the forced
swim test. Both Carlezon et al. [4] and Ferraz et al. [7] however, do
report effects of n-3PUFAs in the forced swim test, and others
report these same effects e.g. [33,36]. The forced swim test,
however, is stressful for animals in itself [3], and thus may
demonstrate effects more under acute stress than under no
stress. Other studies though have also found beneﬁcial effects of
n-3PUFAs in other tests under stress-free conditions e.g. [36],
but these studies are relatively few. A lack of effects of
n-3PUFAs in our study thus may again reﬂect the mild and gradual
nature of our physiological stressor, and provide further support
for the suggestion that n-3PUFAs may only impact on depression
and anxiety in situations of high stress.
Stress and n-3PUFAs are most plausibly linked via the presence
of n-3PUFAs in the cell membrane to result in the production of
anti-inﬂammatory eicosanoids [39,40]. Evidence of effects of
n-3PUFAs in situations of high stress, but not in situations of mild
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stress (as used here), further suggests that n-3PUFAs may only be
of impact/importance during major or sudden disruptions to
inﬂammatory systems, or at a major or sudden onset of inﬂam-
matory conditions. Of relevance to human conditions, n-3PUFAs
then may be of beneﬁt where depression and/or anxiety have
resulted from major or sudden disruptions, such as bereavement
or signiﬁcant life changes, but may be less beneﬁcial in situations
of prolonged low levels of disruption, such as mild daily stressors
or gradual lifestyle changes.
The suggestion of limited effects of n-3PUFAs in the absence of
high stress mirrors current thinking in work with humans. Several
studies conducted on humans now report limited or no effects of
n-3PUFAs in individuals with either no or mild symptoms of
anxiety, depression or stress e.g. [41], although possible effects
are suggested in those suffering from more severe symptoms e.g.
see [2]. Further work on the distinction between those conditions
that may be affected and those conditions that are unlikely to be
affected by n-3PUFAs is clearly required.
Limited methodological reasons may explain our lack of effects
of n-3PUFAs, although these are unlikely. Previous studies suggest
that the dose and duration of supplementation used here was
adequate for effects to be demonstrated e.g. [4,7,33], and the
number of animals and number of measures used also suggest
likely demonstration of effects, should such effects exist [33]. The
age of the animals at the start of the experimental procedures, the
absence of procedures earlier than this (e.g. during weaning,
pregnancy, or in dams), and the duration of exposure to the diet
may also have limited our chances of ﬁnding effects, but similar
procedures have produced effects in other studies e.g. [4,33].
Effects as a result of bright lighting demonstrate the validity of
the procedures used [3], and strengthen the ﬁndings in relation to
DOCA administration and n-3PUFAs. Greater exposure and earlier
exposure to n-3PUFAs, however may also be of interest. Our
protocol was intended to most closely reﬂect possible human
conditions as a result of mild physiological stress where earlier
intervention may have been unlikely and exposure is unlikely to
be sustained in the absence of demonstrable effects [42], but we
appreciate the value of early intervention and longer exposure for
demonstrating more mechanistic effects. Our one trial forced
swim test may have reduced the chances of demonstrating effects
here, but only one trial has previously demonstrated effects of
anhedonia [36], and has been suggested as a more accurate
reﬂection of emotion in the absence of learning [36]. The absence
of measures of plasma or tissue levels of n-3PUFAs is a limitation,
however previous studies have demonstrated that daily dietary
consumption of n-3PUFAs as provided is sufﬁcient to increase
brain n-3PUFA levels. Chalon et al. [20] used a diet where
n-3PUFAs provided 5% of 6 g fats (compared to our 17% of 5 g
fats) and demonstrate increased n3PUFA concentrations in several
brain regions (although the diets in this study were started in
dams two weeks prior to mating). Huang et al. [33] used a feeding
protocol similar to ours, where n3PUFAs provided 36% of 4 g fats to
demonstrate signiﬁcant differences in brain and RBC membrane
n-3PUFA levels and effects in behavioural tests, and the beha-
vioural effects reported by Carlezon [4] were also obtained using a
dose of n-3PUFAs only slightly higher (0.72 mg/kg body weight/d)
than that used in our study (0.57 g/kg body weight/d).
In conclusion, this is the ﬁrst study of which we are aware, that
investigates the impact of n-3PUFAs under mild gradual physiolo-
gical stress. Our ﬁndings suggest that DOCA administration in the
absence of excess salt results in signiﬁcant disruptions of the
renin–angiotensin–aldosterone system, as well as anxiety beha-
viours in rats. Our ﬁndings also demonstrate no effects of
n-3PUFAs under conditions of mild stress. Further studies will
contribute to our understanding of the potential beneﬁts of
n-3PUFAs under different levels of stress, and can therefore aid
in the development of novel treatments for individuals with
depressive or anxiety disorders.
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